Tor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.
Tor and ephrinA1 ligand in solid tumors: function and therapeutic targeting. Mol Ro4402257 site Cancer Res 2008, 6:1795-1806. 33. Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, et al: Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis. Mol Cancer Res 2002, 1:2-11. 34. Shain KH, Yarde DN, Meads MB, Huang M, Jove R, Hazlehurst LA, et al: Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation. Cancer Res 2009, 69:1009-1015. 35. Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, et al: Inhibition of p-STAT3 Enhances IFN-alpha Efficacy against Metastatic Melanoma in a Murine Model. Clin Cancer Res 2010, 16:2550-2561. 36. Dolado I, Swat A, Ajenjo N, De VG, Cuadrado A, Nebreda AR: p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 2007, 11:191-205. 37. Dumka D, Puri P, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/26080418 Carayol N, Lumby C, Balachandran H, Schuster K, et al: Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib. Leuk Lymphoma 2009, 50:2017-2029. 38. Wagner EF, Nebreda AR: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009, 9:537-549. 39. Zhang H, Ozaki I, Mizuta T, Matsuhashi S, Yoshimura T, Hisatomi A, et al: Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway. Cancer 2002, 95:896-906.40. Pavasant P, Yongchaitrakul T: Secreted protein acidic, rich in cysteine induces pulp cell migration via alphavbeta3 integrin and extracellular signal-regulated kinase. Oral Dis 2008, 14:335-340. 41. Sawhney RS, Cookson MM, Omar Y, Hauser J, Brattain MG: Integrin alpha2mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway. J Biol Chem 2006, 281:8497-8510. 42. Saleem S, Li J, Yee SP, Fellows GF, Goodyer CG, Wang R: beta1 integrin/ FAK/ERK signalling pathway is essential for human fetal islet cell differentiation and survival. J Pathol 2009, 219:182-192. 43. Schmidmaier R, Baumann P: ANTI-ADHESION evolves to a promising therapeutic concept in oncology. Curr Med Chem 2008, 15:978-990.doi:10.1186/1476-4598-9-278 Cite this article as: Caccia et al.: Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line. Molecular Cancer 2010 9:278.Submit your next manuscript to BioMed Central and take full advantage of:?Convenient online submission ?Thorough peer review ?No space constraints or color figure charges ?Immediate publication on acceptance ?Inclusion in PubMed, CAS, Scopus and Google Scholar ?Research which is freely available for redistributionSubmit your manuscript at www.biomedcentral.com/submit
?SMRT HDAC3 TF? MetabolitesCK2 HDAC3 TFSMRTCo-activator complex HAT TFHDAC3 SMRT TFNucleusSMRT HDACCytoplasm??(SFN brief exposure?) DegradationHDAC3 Pin1 HDAC(SFN prolonged exposure?)Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/ SMRT corepressor complex dissociation/ reassemblyRajendran et al.Rajendran et al. Molecular Cancer 2011, 10:68 http://www.molecular-cancer.com/content/10/1/68 (30 May 2011)Rajendran et al. Molecular Cancer 2011, 10:68 http://www.molecular-cancer.com/con.